当前位置: X-MOL 学术Medicine, Health Care and Philosophy › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Commodification of biomaterials and data when funding is contingent to transfer in biobank research
Medicine, Health Care and Philosophy ( IF 2.3 ) Pub Date : 2021-07-20 , DOI: 10.1007/s11019-021-10042-3
Mantombi Maseme 1, 2
Affiliation  

It is common practice for biobanks and biobank researchers to seek funding from agencies that are independent of the biobank that often stipulate conditions requiring researchers to grant access and share biomaterials and data as part of the agreement, in particular, in international collaborative health research. As yet, to the author’s knowledge, there has been no study conducted to examine whether these conditions could result in the commercialization of biomaterials and data and whether such practice is considered ethical. This paper therefore seeks to answer the question of whether such sharing of biomaterials and data for biobank research in exchange for funding from sponsors and funders in collaborative health research is ethically justified. The central idea of this paper is based on an argument against commodification of the body and its parts, which includes biomaterials and data and holds that it is ethically wrong to commodify humans and their body parts. The arguments against commodification of biomaterials and data explored are the Kantian approach argument as it relates to interference of commodification with human dignity which is linked to a diminished sense of personhood, an argument against commodification that is based on a dilution of altruism and lastly the communitarian approach anti-commodification argument which emphasizes a social responsibility to the common good. Arguments in support of commodification based on liberal individualism and consequentialism are also discussed.



中文翻译:

当资金可能会转移到生物库研究中时,生物材料和数据的商品化

生物库和生物库研究人员通常会从独立于生物库的机构寻求资金,这些机构通常规定条件,要求研究人员作为协议的一部分授予访问和共享生物材料和数据的权限,特别是在国际合作卫生研究中。迄今为止,据作者所知,尚未进行任何研究来检查这些条件是否会导致生物材料和数据的商业化,以及这种做法是否被认为是合乎道德的。因此,本文试图回答这样一个问题,即这种共享生物材料和数据用于生物库研究以换取合作健康研究的赞助商和资助者的资金是否在道德上是合理的。本文的中心思想是基于反对将人体及其部位商品化的论点,其中包括生物材料和数据,并认为将人类及其身体部位商品化在伦理上是错误的。反对生物材料和数据商品化的论点是康德方法论点,因为它涉及商品化对人类尊严的干扰,这与人格感的减弱有关,反对商品化的论点是基于利他主义的稀释,最后是社群主义接近反商品化的论点,强调对共同利益的社会责任。还讨论了支持基于自由个人主义和后果主义的商品化的论点。其中包括生物材料和数据,并认为将人类及其身体部位商品化在道德上是错误的。反对生物材料和数据商品化的论点是康德方法论点,因为它涉及商品化对人类尊严的干扰,这与人格感的减弱有关,反对商品化的论点是基于利他主义的稀释,最后是社群主义接近反商品化的论点,强调对共同利益的社会责任。还讨论了支持基于自由个人主义和后果主义的商品化的论点。其中包括生物材料和数据,并认为将人类及其身体部位商品化在道德上是错误的。反对生物材料和数据商品化的论点是康德方法论点,因为它涉及商品化对人类尊严的干扰,这与人格感的减弱有关,反对商品化的论点是基于利他主义的稀释,最后是社群主义接近反商品化的论点,强调对共同利益的社会责任。还讨论了支持基于自由个人主义和后果主义的商品化的论点。反对生物材料和数据商品化的论点是康德方法论点,因为它涉及商品化对人类尊严的干扰,这与人格感的减弱有关,反对商品化的论点是基于利他主义的稀释,最后是社群主义接近反商品化的论点,强调对共同利益的社会责任。还讨论了支持基于自由个人主义和后果主义的商品化的论点。反对生物材料和数据商品化的论点是康德方法论点,因为它涉及商品化对人类尊严的干扰,这与人格感的减弱有关,反对商品化的论点是基于利他主义的稀释,最后是社群主义接近反商品化的论点,强调对共同利益的社会责任。还讨论了支持基于自由个人主义和后果主义的商品化的论点。

更新日期:2021-07-22
down
wechat
bug